ArticleClinical and translational science2018

Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies.

Holger Rosenbrock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.